DXCM Q2 2019 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$336M+38.7% YoY

Gross Profit

$207M61.4% margin

Operating Income

-$800,000-0.2% margin

Net Income

-$11M-3.1% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

$65M

Free Cash Flow

$18M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.4B

Stockholders' Equity

$688M

Cash & Equivalents

$709M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$336M	$243M	+38.7%
Gross Profit	$207M	$154M	+34.4%
Operating Income	-$800,000	-$5M	+83.7%
Net Income	-$11M	$30M	-134.8%

Geographic Segments

UNITED STATES

$266M79%

Non-US

$70M21%